Home Amines 106139-15-5
106139-15-5,MFCD01863453
Catalog No.:AA0035ZT

106139-15-5 | (S)-2-Pyridylthio cysteamine, HCl

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$81.00   $57.00
- +
250mg
97%
in stock  
$95.00   $67.00
- +
1g
97%
in stock  
$100.00   $70.00
- +
5g
97%
in stock  
$188.00   $132.00
- +
10g
97%
in stock  
$374.00   $262.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0035ZT
Chemical Name:
(S)-2-Pyridylthio cysteamine, HCl
CAS Number:
106139-15-5
Molecular Formula:
C7H11ClN2S2
Molecular Weight:
222.7586
MDL Number:
MFCD01863453
SMILES:
NCCSSc1ccccn1.Cl
Properties
Properties
 
Form:
Solid  
MP:
123-126˚C  
Storage:
Room Temperature;  

Computed Properties
 
Complexity:
100  
Covalently-Bonded Unit Count:
2  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
4  

Downstream Synthesis Route
2127-03-9    156-57-0   
2-(2-pyridinyl)dithioethanaminehydrochloride 

[1]Lelle,Marco;Peneva,Kalina[AminoAcids,2014,vol.46,#5,p.1243-1251]

[2]Lelle,Marco;Freidel,Christoph;Kaloyanova,Stefka;Tabujew,Ilja;Schramm,Alexander;Musheev,Michael;Niehrs,Christof;Müllen,Klaus;Peneva,Kalina[EuropeanJournalofMedicinalChemistry,2017,vol.130,p.336-345]

[3]Huang,Zhiyong;Li,Shen-Huan;Long,Cheng-Yu;Tan,Weihong;Wang,Dan;Wang,Xue-Qiang[JournaloftheAmericanChemicalSociety,2021,vol.143,#23,p.8559-8564]

[4]Lelle,Marco;Frick,StefanieU.;Steinbrink,Kerstin;Peneva,Kalina[JournalofPeptideScience,2014,vol.20,#5,p.323-333]

[5]Vega,DanielL.;Lodge,Patrick;Vivero-Escoto,JuanL.[InternationalJournalofMolecularSciences,2016,vol.17,#1]

[6]-CN114106012,2022,ALocationinpatent:Paragraph0032;0040-0041

[7]CurrentPatentAssignee:HelmholtzAssociation-WO2019/30284,2019,A1Locationinpatent:Paragraph00191;00192

[8]CurrentPatentAssignee:DAREBIOSCIENCEINC-US2014/37573,2014,A1Locationinpatent:Paragraph0958-0959

[9]CurrentPatentAssignee:DAREBIOSCIENCEINC-WO2015/57847,2015,A1Locationinpatent:Page/Pagecolumn195

[10]CurrentPatentAssignee:YANTAIINSTOFMATERIAMEDICA-CN110314237,2019,ALocationinpatent:Paragraph0060-0065;0073

[11]Gnaccarini,Claudio;Peter,Sascha;Scheffer,Ute;Vonhoff,Stefan;Klussmann,Sven;Goebel,MichaelW.[JournaloftheAmericanChemicalSociety,2006,vol.128,#24,p.8063-8067]

[12]Isono,Aoi;Tsuji,Mieko;Sanada,Yu;Matsushita,Akari;Masunaga,Shinichiro;Hirayama,Tasuku;Nagasawa,Hideko[ChemMedChem,2019]

[13]CurrentPatentAssignee:UNIVERSITYOFMASSACHUSETTS-US2015/209447,2015,A1Locationinpatent:Paragraph0273;0274

[14]CurrentPatentAssignee:UNIVERSITYOFMASSACHUSETTS-US9795689,2017,B2Locationinpatent:Page/Pagecolumn54;55

[15]CurrentPatentAssignee:UNIVERSITYOFMASSACHUSETTS-US2019/83649,2019,A1Locationinpatent:Paragraph0272;0273

[16]CurrentPatentAssignee:FUNDACIÓNIMDEANANOCIENCIA-US2016/75680,2016,A1Locationinpatent:Paragraph0092;0093

[17]Wang,Long-Hai;Wu,De-Cheng;Xu,Hang-Xun;You,Ye-Zi[AngewandteChemie-InternationalEdition,2016,vol.55,#2,p.755-759][Angew.Chem.,2016,vol.128,#2,p.765-769,5]

[18]Kufka,Rainer;Rennert,Robert;Kaluđerović,GoranN.;Weber,Lutz;Richter,Wolfgang;Wessjohann,LudgerA.[BeilsteinJournalofOrganicChemistry,2019,vol.15,p.96-105]

[19]Zugates,GregoryT.;Anderson,DanielG.;Little,StevenR.;Lawhorn,IngridE.B.;Langer,Robert[JournaloftheAmericanChemicalSociety,2006,vol.128,#39,p.12726-12734]

[20]Liu,Rui;Zhang,Ying;Feng,Pingyun[JournaloftheAmericanChemicalSociety,2009,vol.131,#42,p.15128-15129]

[21]CurrentPatentAssignee:DAREBIOSCIENCEINC-WO2012/44832,2012,A1Locationinpatent:Page/Pagecolumn628

[22]CurrentPatentAssignee:ELLIPSESPHARMALIMITED-WO2011/63421,2011,A1Locationinpatent:Page/Pagecolumn242

[23]Sugawara,Yuuki;Tamaki,Takanori;Ohashi,Hidenori;Yamaguchi,Takeo[SoftMatter,2013,vol.9,#12,p.3331-3340]

[24]Tsuji,Mieko;Ueda,Satoshi;Hirayama,Tasuku;Okuda,Kensuke;Sakaguchi,Yoshiaki;Isono,Aoi;Nagasawa,Hideko[OrganicandBiomolecularChemistry,2013,vol.11,#18,p.3030-3037]

[25]CurrentPatentAssignee:INDIANAUNIVERSITY-WO2013/74910,2013,A1Locationinpatent:Paragraph00875

[26]CurrentPatentAssignee:INDIANAUNIVERSITY-US9127088,2015,B2Locationinpatent:Page/Pagecolumn253;254

[27]Ju,Yuanyuan;Xing,Cheng;Wu,Dongxia;Wu,Yunfang;Wang,Lianyong;Zhao,Hanying[Chemistry-AEuropeanJournal,2017,vol.23,#14,p.3366-3374]

[28]CurrentPatentAssignee:WUHANUNIVERSITYOFTECHNOLOGY-CN110917360,2020,ALocationinpatent:Page/Pagecolumn6;9-12

[1]CurrentPatentAssignee:PERKINELMERINC-WO2007/28118,2007,A2Locationinpatent:Page/Pagecolumn48

928027-78-5    106139-15-5   
CASUnavailable 

[1]CurrentPatentAssignee:CISCOSYSTEMSINC;PERKINELMERINC-WO2007/28037,2007,A1Locationinpatent:Page/Pagecolumn77-78

[1]CurrentPatentAssignee:IMMUNOGENINC-WO2010/91150,2010,A1Locationinpatent:Page/Pagecolumn158

[1]Tsuji,Mieko;Ueda,Satoshi;Hirayama,Tasuku;Okuda,Kensuke;Sakaguchi,Yoshiaki;Isono,Aoi;Nagasawa,Hideko[OrganicandBiomolecularChemistry,2013,vol.11,#18,p.3030-3037]

Literature

Title: Lelle M, et al. Octreotide-Mediated Tumor-Targeted Drug Delivery via a Cleavable Doxorubicin-Peptide Conjugate. Mol Pharm. 2015 Dec 7;12(12):4290-300.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 106139-15-5
Tags:106139-15-5 Molecular Formula|106139-15-5 MDL|106139-15-5 SMILES|106139-15-5 (S)-2-Pyridylthio cysteamine, HCl